Search Results - "Margalit, Danielle N"

Refine Results
  1. 1
  2. 2

    The Benefits of Adjuvant Trastuzumab for HER‐2‐Positive Salivary Gland Cancers by Hanna, Glenn J., Bae, Ji Eun, Lorch, Jochen H., Haddad, Robert I., Jo, Vickie Y., Schoenfeld, Jonathan D., Margalit, Danielle N., Tishler, Roy B., Goguen, Laura A., Annino, Donald J., Chau, Nicole G.

    Published in The oncologist (Dayton, Ohio) (01-07-2020)
    “…Background Although high‐grade salivary gland cancers (SGCs) often express androgen receptor (AR) and/or HER‐2/neu, therapeutically targeting these receptors…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma by Hanna, Glenn J., Bae, Ji Eun, Lorch, Jochen H., Schoenfeld, Jonathan D., Margalit, Danielle N., Tishler, Roy B., Haddad, Robert I., Chau, Nicole G.

    Published in Oral oncology (01-07-2020)
    “…•ACC patients treated within 3 years of recurrent, metastatic diagnosis have poor outcomes.•Disease biology drives prognosis in ACC, despite the use of…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Everolimus in Anaplastic Thyroid Cancer: A Case Series by Harris, Ethan J, Hanna, Glenn J, Chau, Nicole, Rabinowits, Guilherme, Haddad, Robert, Margalit, Danielle N, Schoenfeld, Jonathan, Tishler, Roy B, Barletta, Justine A, Nehs, Matthew, Janne, Pasi, Huang, Julian, Groden, Phillip, Kacew, Alec, Lorch, Jochen

    Published in Frontiers in oncology (26-02-2019)
    “…Anaplastic thyroid cancer (ATC) is a very aggressive disease and accounts for over 50% of thyroid-cancer related deaths. mTOR inhibition has shown anti-tumor…”
    Get full text
    Journal Article
  9. 9

    Microinvasive Breast Cancer: ER, PR, and HER-2/neu Status and Clinical Outcomes after Breast-Conserving Therapy or Mastectomy by Margalit, Danielle N., Sreedhara, Meera, Chen, Yu-Hui, Catalano, Paul J., Nguyen, Paul L., Golshan, Mehra, Overmoyer, Beth A., Harris, Jay R., Brock, Jane E.

    Published in Annals of surgical oncology (01-03-2013)
    “…Background Contemporary clinical outcomes of microinvasive breast cancer (MIBC), defined as no focus >1 mm, are not well characterized. We document the…”
    Get full text
    Journal Article
  10. 10

    Targeting Cell Division: Small-Molecule Inhibitors of FtsZ GTPase Perturb Cytokinetic Ring Assembly and Induce Bacterial Lethality by Margalit, Danielle N., Romberg, Laura, Mets, Rebecca B., Hebert, Alan M., Mitchison, Timothy J., Kirschner, Marc W., RayChaudhuri, Debabrata

    “…FtsZ, the ancestral homolog of eukaryotic tubulins, is a GTPase that assembles into a cytokinetic ring structure essential for cell division in prokaryotic…”
    Get full text
    Journal Article
  11. 11

    Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer by Keane, Florence K., Chen, Yu-Hui, Tishler, Roy B., Schoenfeld, Jonathan D., Haddad, Robert I., Goguen, Laura A., Catalano, Paul, Neville, Bridget A., Margalit, Danielle N.

    Published in Head & neck (01-10-2016)
    “…Background The American Joint Committee on Cancer (AJCC) staging system does not adequately distinguish prognostic groups in the era of human papillomavirus…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Radiation Oncology—New Approaches in Squamous Cell Cancer of the Head and Neck by Margalit, Danielle N., MD, MPH, Schoenfeld, Jonathon D., MD, MPH, Tishler, Roy B., MD, PhD

    “…The many advances in radiotherapy for squamous cell cancer of the head and neck described in this article will have significant effects on the ultimate…”
    Get full text
    Journal Article
  14. 14

    Active Tobacco Smoking and Distant Metastasis in Patients With Oropharyngeal Cancer by McBride, Sean M., M.D, Ali, Nawal N., B.S, Margalit, Danielle N., M.D., M.P.H, Chan, Annie W., M.D

    “…Purpose Distant metastasis is the site of first relapse in approximately one-third of patients with locally advanced oropharyngeal carcinoma, irrespective of…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Head and Neck Cancer Clinical Research on ClinicalTrials.gov: An Opportunity for Radiation Oncologists by Muralidhar, Vinayak, Giacalone, Nicholas J., Milani, Nastaran, Schoenfeld, Jonathan D., Tishler, Roy B., Rawal, Bhupendra, Margalit, Danielle N.

    Published in Advances in radiation oncology (01-05-2021)
    “…Many improvements in head and neck cancer (HNC) outcomes are related to optimization of radiation therapy (RT) dose, fractionation, normal-tissue sparing, and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States by Mahal, Brandon A, Catalano, Paul J, Haddad, Robert I, Hanna, Glenn J, Kass, Jason I, Schoenfeld, Jonathan D, Tishler, Roy B, Margalit, Danielle N

    “…Human papillomavirus (HPV)-positive oropharyngeal head and neck squamous cell carcinoma (OPSCC) is increasing in the United States. Current epidemiologic…”
    Get full text
    Journal Article
  20. 20